Literature DB >> 500381

Increased risk of diabetes mellitus in beta- thalassemia major due to iron overload.

K Zuppinger, B Molinari, A Hirt, P Imbach, E Gugler, O Tönz, R P Zurbrügg.   

Abstract

Frequent transfusions improve the general well being in patients with beta-thalassemia major but carry the risk of iron intoxication including the development of diabetes mellitus. Of 22 patients with beta-thalassemia major (age 3-17 years) only 3 had a normal oral glucose tolerance. The remainder had either borderline or moderately pathological glucose curves. The mean glucose concentration was increased, and the mean insulin concentration and insulin/glucose ratio were diminished. In contrast to the oral test, the i.v. glucose tolerance test gave pathological results in only 2 of 16 patients tested. The i.v. glucose test thus may be less selective than the oral test. The mean insulin concentration was lower also after intravenous glucose, but the early insulin peak was preserved. Arginine infusion led to a normal insulin and growth hormone release. This moderate impairment of insulin release found in most of the patients leaves the hope that an efficient chelating therapy scheme might reverse beta-cell dysfunction.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 500381

Source DB:  PubMed          Journal:  Helv Paediatr Acta        ISSN: 0018-022X


  10 in total

1.  Insulin dependent diabetes in thalassaemia.

Authors:  V De Sanctis; M G Zurlo; E Senesi; C Boffa; L Cavallo; F Di Gregorio
Journal:  Arch Dis Child       Date:  1988-01       Impact factor: 3.791

Review 2.  Growth and endocrine function in thalassemia major in childhood and adolescence.

Authors:  M Delvecchio; L Cavallo
Journal:  J Endocrinol Invest       Date:  2010-01       Impact factor: 4.256

Review 3.  Acquired non-type 1 diabetes in childhood: subtypes, diagnosis, and management.

Authors:  J R Porter; T G Barrett
Journal:  Arch Dis Child       Date:  2004-12       Impact factor: 3.791

4.  Sodium, Magnesium, Calcium, Manganese, Iron, Copper, and Zinc in Serums of Beta Thalassemia Major Patients.

Authors:  Ayşe Şahin; Elif Öztürk Er; Ersoy Öz; Zeynep Yıldız Yıldırmak; Sezgin Bakırdere
Journal:  Biol Trace Elem Res       Date:  2020-05-28       Impact factor: 3.738

5.  Three-year prospective evaluation of glucose tolerance, beta-cell function and peripheral insulin sensitivity in non-diabetic patients with thalassemia major.

Authors:  M F Messina; F Lombardo; A Meo; M Miceli; M Wasniewska; M Valenzise; C Ruggeri; T Arrigo; F De Luca
Journal:  J Endocrinol Invest       Date:  2002-06       Impact factor: 4.256

6.  The development of diabetes mellitus and chronic liver disease in long term chelated beta thalassaemic patients.

Authors:  V De Sanctis; G D'Ascola; B Wonke
Journal:  Postgrad Med J       Date:  1986-09       Impact factor: 2.401

7.  Study of A- and B-cell function in beta-thalassemia major.

Authors:  M Maioli; A Pacifico; T Frulio; M Longinotti
Journal:  Acta Diabetol Lat       Date:  1983 Apr-Jun

Review 8.  Metabolism and possible health effects of aluminum.

Authors:  P O Ganrot
Journal:  Environ Health Perspect       Date:  1986-03       Impact factor: 9.031

9.  Glucose homeostasis in Egyptian children and adolescents with β-Thalassemia major: Relationship to oxidative stress.

Authors:  Kotb Abbass Metwalley; Abdel-Rahman Abdel-Hamed El-Saied
Journal:  Indian J Endocrinol Metab       Date:  2014-05

10.  Prevalence of iron overload complications among patients with b-thalassemia major treated at Dubai Thalassemia Centre.

Authors:  Khawla Mohammed Belhoul; Maisan Lateef Bakir; Ahmed Mohamed Kadhim; Hany ElSayed Dewedar; Mohamed Salah Eldin; Fatheya Abbas Alkhaja
Journal:  Ann Saudi Med       Date:  2013 Jan-Feb       Impact factor: 1.526

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.